Fecal Immunoglobulin Levels as a Modifier of the Gut Microbiome in Patients with Common Variable Immunodeficiency.
Christina NöltnerAlla BulashevskaKatrin HübscherHanna HaberstrohBodo GrimbacherMichele ProiettiPublished in: Journal of clinical immunology (2023)
CVID patients have an altered gut microbiota composition, which is most prevalent in patients with decreased fecal IgA and IgM levels. In this study, we identify fecal immunoglobulins as a potential modifier of the gut microbiome in CVID patients.